Chlamydia pneumoniae and Heart Disease Risk in Diabetic Patients
Author Information
Author(s): Guech-Ongey Mercy, Brenner Hermann, Twardella Dorothee, Rothenbacher Dietrich
Primary Institution: German Centre for Research on Ageing, University of Heidelberg
Hypothesis
Is there an association between Chlamydia pneumoniae infection and the risk of secondary cardiovascular events in patients with coronary heart disease, particularly those with diabetes?
Conclusion
The study suggests a possible moderate increase in risk of secondary cardiovascular events among patients with a positive infection sero-status, but no intermediate role of human heat shock protein 60 was found.
Supporting Evidence
- 37.4% of participants were sero-positive for Chlamydia pneumoniae IgA.
- 71 secondary cardiovascular events occurred during the follow-up.
- The risk of secondary CVD events was higher in sero-positive patients with diabetes.
Takeaway
This study looked at whether a certain germ could make heart problems worse for people with diabetes. It found that having the germ might slightly increase the risk of more heart issues.
Methodology
Patients aged 30–70 with coronary heart disease were followed for secondary cardiovascular events over a mean period of 33.5 months, with sero-status for Chlamydia pneumoniae and heat shock proteins measured.
Potential Biases
Potential selection bias due to the exclusion of patients who could not participate in rehabilitation programs.
Limitations
The study may not represent severely ill patients as those unable to participate in rehabilitation were excluded, and the low occurrence of fatal events limits the findings.
Participant Demographics
84.9% male, mean age 60 years, 19.3% had a history of diabetes.
Statistical Information
P-Value
0.04 for CP IgA, 0.1 for CP IgG
Confidence Interval
95% CI 1.01–2.55 for CP IgA
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website